New COVID-19 Cases Remain in the 400s for Three Consecutive Days... 1,073 Additional Vaccine Adverse Reactions Reported (Update)

Local Cases 444, Imported Cases 21

On the 21st, citizens are getting tested at the temporary COVID-19 screening site set up at Seoul Station Plaza. The Central Disease Control Headquarters announced that as of midnight that day, there were 416 new confirmed COVID-19 cases in the country, bringing the total to 86,992. Photo by Moohonam Mun. munonam@

[Asia Economy Reporter Kim Ji-hee] The number of new COVID-19 cases in South Korea has remained in the 400s for three consecutive days.

The Central Disease Control Headquarters (CDCH) announced that as of midnight on the 11th, there were 465 new COVID-19 cases reported domestically, bringing the total to 94,198. Of these, 444 cases were locally transmitted and 21 were imported.

By region, the Seoul metropolitan area accounted for a large proportion with 137 cases in Seoul, 178 in Gyeonggi, and 18 in Incheon. Outside the metropolitan area, Gangwon reported 30 cases, Ulsan 23, Busan 13, North Gyeongsang 10, North Jeolla and South Gyeongsang 7 each, North Chungcheong 6, Daegu and South Chungcheong 4 each, South Jeolla 3, Jeju 2, and Gwangju and Daejeon 1 each. No new cases were reported in Sejong.

Among the 21 imported cases, 10 were identified during quarantine, and 11 were detected within the local community. Eleven were Korean nationals and 10 were foreigners.

The cumulative death toll from COVID-19 increased by 4 from the previous day. The number of critically ill patients rose by 4 to 127. The number of patients who have recovered and been released from isolation increased by 363, totaling 84,675.

On this day, 38,101 diagnostic tests were conducted on suspected cases, and 29,747 tests were performed at temporary screening clinics set up in the metropolitan area, confirming 82 positive cases.

Additionally, the COVID-19 Vaccination Response Promotion Team reported that as of midnight, 51,100 people received additional COVID-19 vaccine doses, bringing the total number of people who completed the first dose to 500,635. Among them, 487,704 received the AstraZeneca vaccine, and 12,931 received the Pfizer vaccine.

There were 1,073 new reports of suspected adverse reactions, bringing the total to 6,859. Of these, 6,782 were mild cases such as headaches, fever, and nausea. Reports of suspected anaphylaxis increased by 7, totaling 57 cases. No additional deaths following vaccination have been reported.

This content was produced with the assistance of AI translation services.